Skip to content

Psychedelic Stocks

2 Psychedelic Stocks That Will Skyrocket, According To Wall Street

Psychedelics—psychotropic drugs that trigger altered states of consciousness—are gaining widespread attention. Over the past two decades, research in the area has increased, with a magic mushroom ingredient—psilocybin—showing promise for treating a range of mental health disorders and addictions. In addition, a CB Insights market research report has shown that psychedelic medicine funding was set to cross $700 million in 2021, which is… 

CLICK HERE »2 Psychedelic Stocks That Will Skyrocket, According To Wall Street

“The Trip Of Your Life”: How To Profit From The “Shroom Boom”

“I think this is the ground floor of a market that could be worth more than $29 billion by the end of the decade,” declares the author of today’s article of the “New Biotech” sector he discusses: psychedelics. For more on the potential profit opportunities associated with the “Shroom Boom” – especially in light of recent news regarding an important, successful FDA… 

CLICK HERE »“The Trip Of Your Life”: How To Profit From The “Shroom Boom”

With Many Psychedelic Stocks Posting Triple-Digit Returns, The “Shroom Boom” May Just Be Beginning

While biotech stocks have been hot over the last year, today’s article notes that another group of stocks have been trading like biotech companies of late: psychedelic stocks. In fact, a slew of psychedelic stocks have posted triple-digit returns over the last year – and with the impending release of studies examining the use of psychedelics to treat mental health… 

CLICK HERE »With Many Psychedelic Stocks Posting Triple-Digit Returns, The “Shroom Boom” May Just Be Beginning